Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MacLean Hall

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Dimensions of Critical Care Nursing : DCCN|May 28, 2026
Quantitative Pupillometry Values Are Similar in Bright Light and Dim Light ConditionsKylie MacLean Hall, Jennifer Wilson, Ty A Johnson, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumorsMacLean Hall, Hao Liu, Mokenge Malafa, et al.
Journal of Translational Medicine|July 14, 2012
Biomarkers on melanoma patient T cells associated with ipilimumab treatmentWenshi Wang, Daohai Yu, Amod A Sarnaik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2020
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid CellsPatrick Innamarato, Sarah Asby, Jennifer Morse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanomaAmod A Sarnaik, Bin Yu, Daohai Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
Frontiers in Immunology|March 30, 2026
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancerOluwaseyi Oluwatola, Sarah Bazargan, Pietro Irrera, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 14, 2021
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific FunctionJohn E Mullinax, MacLean Hall, Matthew Beatty, et al.
Frontiers in Oncology|March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaJohn E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Dimensions of Critical Care Nursing : DCCN|May 28, 2026
Quantitative Pupillometry Values Are Similar in Bright Light and Dim Light ConditionsKylie MacLean Hall, Jennifer Wilson, Ty A Johnson, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumorsMacLean Hall, Hao Liu, Mokenge Malafa, et al.
Journal of Translational Medicine|July 14, 2012
Biomarkers on melanoma patient T cells associated with ipilimumab treatmentWenshi Wang, Daohai Yu, Amod A Sarnaik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2020
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid CellsPatrick Innamarato, Sarah Asby, Jennifer Morse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanomaAmod A Sarnaik, Bin Yu, Daohai Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
Frontiers in Immunology|March 30, 2026
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancerOluwaseyi Oluwatola, Sarah Bazargan, Pietro Irrera, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 14, 2021
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific FunctionJohn E Mullinax, MacLean Hall, Matthew Beatty, et al.
Frontiers in Oncology|March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaJohn E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Pageof 2